Rhinitis medicamentosa
BMJ Case Rep
.
2021 Nov 9;14(11):e247051.
doi: 10.1136/bcr-2021-247051.
Authors
Lok-Yee Joyce Li
1
2
,
Shin-Yi Wang
3
,
Cheng-Yu Tsai
4
,
Cheng-Jung Wu
5
6
7
Affiliations
1
Department of Medicine, Shin Kong Wu Ho Su Memorial Hospital, Taipei, Taiwan.
2
Department of Otolaryngology, School of Medicine, College of Medicine,Taipei Medical University, Taipei, Taiwan.
3
Department of Nursing, National Taiwan University Hospital, Hsin-Chu Branch, Hsinchu, Taiwan.
4
Department of Civil and Environmental Engineering, Imperial College London, London, London, UK.
5
Department of Otolaryngology, School of Medicine, College of Medicine,Taipei Medical University, Taipei, Taiwan B101090126@tmu.edu.tw.
6
Department of Otolaryngology, Shuang Ho Hospital Ministry of Health and Welfare, Taipei Medical University, New Taipei City, Taiwan.
7
PhD Degree Program of Biomedical Science and Engineering, National Yang Ming Chiao Tung University, Hsinchu, Taiwan.
PMID:
34753736
PMCID:
PMC8578967
DOI:
10.1136/bcr-2021-247051
No abstract available
Keywords:
drugs and medicines; ear; nose and throat.
Publication types
Case Reports
MeSH terms
Administration, Intranasal
Humans
Nasal Mucosa
Rhinitis* / chemically induced
Rhinitis* / drug therapy